KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Raw Materials (2016 - 2019)

Historic Raw Materials for NovoCure (NVCR) over the last 6 years, with Q2 2019 value amounting to $3.4 million.

  • NovoCure's Raw Materials rose 3620.48% to $3.4 million in Q2 2019 from the same period last year, while for Jun 2019 it was $3.4 million, marking a year-over-year increase of 3620.48%. This contributed to the annual value of $870000.0 for FY2018, which is 7965.39% down from last year.
  • As of Q2 2019, NovoCure's Raw Materials stood at $3.4 million, which was up 3620.48% from $1.5 million recorded in Q1 2019.
  • In the past 5 years, NovoCure's Raw Materials registered a high of $5.9 million during Q3 2017, and its lowest value of $870000.0 during Q4 2018.
  • Moreover, its 5-year median value for Raw Materials was $3.6 million (2015), whereas its average is $3.6 million.
  • In the last 5 years, NovoCure's Raw Materials soared by 56882.13% in 2015 and then crashed by 7965.39% in 2018.
  • Quarter analysis of 5 years shows NovoCure's Raw Materials stood at $3.5 million in 2015, then surged by 49.03% to $5.2 million in 2016, then dropped by 18.44% to $4.3 million in 2017, then plummeted by 79.65% to $870000.0 in 2018, then surged by 294.37% to $3.4 million in 2019.
  • Its last three reported values are $3.4 million in Q2 2019, $1.5 million for Q1 2019, and $870000.0 during Q4 2018.